Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Suriya, Jeyapalan"'
Autor:
Priscilla K. Brastianos, Erin L. Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Jochen Lennerz, Suriya Jeyapalan, David E. Piccioni, Varun Monga, Camilo E. Fadul, David Schiff, Jennie W. Taylor, Sajeel A. Chowdhary, Chetan Bettegowda, George Ansstas, Macarena De La Fuente, Mark D. Anderson, Nicole Shonka, Denise Damek, Jose Carrillo, Lara J. Kunschner-Ronan, Rekha Chaudhary, Kurt A. Jaeckle, Francis M. Senecal, Thomas Kaley, Tara Morrison, Alissa A. Thomas, Mary R. Welch, Fabio Iwamoto, David Cachia, Adam L. Cohen, Shivangi Vora, Michael Knopp, Ian F. Dunn, Priya Kumthekar, Jann Sarkaria, Susan Geyer, Xiomara W. Carrero, Maria Martinez-Lage, Daniel P. Cahill, Paul D. Brown, Caterina Giannini, Sandro Santagata, Frederick G. Barker, Evanthia Galanis
Publikováno v:
Journal of Clinical Oncology. 41:618-628
PURPOSE Patients with progressive or recurrent meningiomas have limited systemic therapy options. Focal adhesion kinase (FAK) inhibition has a synthetic lethal relationship with NF2 loss. Given the predominance of NF2 mutations in meningiomas, we eva
Autor:
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Isabella Perron, Hui Zhang, William J Gradishar, Elena I Pentsova, Suriya Jeyapalan, Morris D Groves, Michelle Melisko, Jeffrey J Raizer
Publikováno v:
Neuro-Oncology. 25:557-565
Background Patients with human epidermal growth factor receptor 2-positive (HER2-positive) cancers have a high incidence of central nervous system (CNS) spread, but unfortunately systemic trastuzumab which targets the HER2 receptor has little CNS pen
Autor:
Martin Glas, Matthew T. Ballo, Ze'ev Bomzon, Noa Urman, Shay Levi, Gitit Lavy-Shahaf, Suriya Jeyapalan, Terence T. Sio, Paul M. DeRose, Martin Misch, Sophie Taillibert, Zvi Ram, Andreas F. Hottinger, Jacob Easaw, Chae-Yong Kim, Suyash Mohan, Roger Stupp
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:1269-1278
Purpose: Tumor-treating fields (TTFields) are an antimitotic treatment modality that interfere with glioblastoma (GBM) cell division and organelle assembly by delivering low-intensity, alternating electric fields to the tumor. A previous analysis fro
Autor:
Priscilla K, Brastianos, Erin L, Twohy, Elizabeth R, Gerstner, Timothy J, Kaufmann, A John, Iafrate, Jochen, Lennerz, Suriya, Jeyapalan, David E, Piccioni, Varun, Monga, Camilo E, Fadul, David, Schiff, Jennie W, Taylor, Sajeel A, Chowdhary, Chetan, Bettegowda, George, Ansstas, Macarena, De La Fuente, Mark D, Anderson, Nicole, Shonka, Denise, Damek, Jose, Carrillo, Lara J, Kunschner-Ronan, Rekha, Chaudhary, Kurt A, Jaeckle, Francis M, Senecal, Thomas, Kaley, Tara, Morrison, Alissa A, Thomas, Mary R, Welch, Fabio, Iwamoto, David, Cachia, Adam L, Cohen, Shivangi, Vora, Michael, Knopp, Ian F, Dunn, Priya, Kumthekar, Jann, Sarkaria, Susan, Geyer, Xiomara W, Carrero, Maria, Martinez-Lage, Daniel P, Cahill, Paul D, Brown, Caterina, Giannini, Sandro, Santagata, Frederick G, Barker, Evanthia, Galanis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Patients with progressive or recurrent meningiomas have limited systemic therapy options. Focal adhesion kinase (FAK) inhibition has a synthetic lethal relationship withEligible patients whose tumors screened positively forOf 322 patients screened fo
Autor:
Anna Skakodub, Lisa M. DeAngelis, Morris D. Groves, Adrienne Boire, Jeffrey Raizer, Michelle E. Melisko, Suriya Jeyapalan, Rachna Malani, Priya Kumthekar, Andrew D. Seidman, Elena Pentsova, Andrew B. Lassman, Xuling Lin, Antonio Omuro, Nan Lin, Marc K. Rosenblum, Martin Fleisher
Publikováno v:
Journal of Neuro-Oncology
Purpose The CellSearch® system has been used to identify circulating tumor cells (CTCs) in cerebrospinal fluid (CSF) to diagnose leptomeningeal metastasis (LM) in patients with epithelial cancers. Using this system, we prospectively explored sequent
Autor:
Wenyin Shi, Lawrence Kleinberg, Suriya Jeyapalan, Samuel A. Goldlust, Seema Nagpal, Stephanie E. Combs, David Roberge, Ryo Nishikawa, David Reardon, Rachel Grossman, Martin Glas
Publikováno v:
WFNOS 2022 Abstract Book.
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Priya U, Kumthekar, Michael J, Avram, Andrew B, Lassman, Nancy U, Lin, Eudocia, Lee, Sean A, Grimm, Margaret, Schwartz, Kirsten L, Bell Burdett, Rimas V, Lukas, Karan, Dixit, Isabella, Perron, Hui, Zhang, William J, Gradishar, Elena I, Pentsova, Suriya, Jeyapalan, Morris D, Groves, Michelle, Melisko, Jeffrey J, Raizer
Publikováno v:
Neuro-oncology.
Patients with human epidermal growth factor receptor 2-positive (HER2-positive) cancers have a high incidence of central nervous system (CNS) spread, but unfortunately systemic trastuzumab which targets the HER2 receptor has little CNS penetration. T
Autor:
Takahisa, Mikami, Bobby, Liaw, Mizuho, Asada, Takahiro, Niimura, Yoshito, Zamami, Deborah, Green-LaRoche, Lori, Pai, Michael, Levy, Suriya, Jeyapalan
Publikováno v:
Journal of neuro-oncology. 152(1)
To investigate the characteristics and risk factors for neurologic adverse events (AEs) induced by immune checkpoint inhibitors (ICIs).An observational, retrospective, and pharmacovigilance study based on the FAERS database collected between January
Autor:
Jeffrey M. Rogg, Robert J. Harris, Jerrold L. Boxerman, Benjamin M. Ellingson, Howard Safran, Whitney B. Pope, Suriya Jeyapalan, Heinrich Elinzano
Publikováno v:
American Journal of Clinical Oncology. 40:228-234
For patients with high-grade glioma on clinical trials it is important to accurately assess time of disease progression. However, differentiation between pseudoprogression (PsP) and progressive disease (PD) is unreliable with standard magnetic resona